Abstract
Low levels of serotonin may reduce the density of the serotonin transporter (SERT) by either increasing trafficking or reducing synthesis; a "neuroadaptive response". To determine whether 3,4-methylenedioxymethamphetamine (MDMA)-induced reductions in SERT density could be related to such a mechanism, p-chlorophenylalanine or MDMA was administered to rats, and brain serotonin and SERT density were measured. As expected, both treatments led to serotonin depletion 1, 7 and 14 days later. However, only MDMA reduced SERT density. This observation suggests that MDMA-induced reductions in SERT density do not represent neuroadaptive responses to decreased levels of brain serotonin, but may occur in response to some other stimulus or to the neurotoxic effects of MDMA.
Publication types
-
Comparative Study
-
Retracted Publication
MeSH terms
-
Animals
-
Autoradiography
-
Brain / drug effects
-
Brain / metabolism
-
Carrier Proteins / metabolism*
-
Cerebellar Cortex / drug effects
-
Chromatography, High Pressure Liquid
-
Fenclonine / pharmacology*
-
Hydroxyindoleacetic Acid / metabolism
-
Male
-
Membrane Glycoproteins / metabolism*
-
Membrane Transport Proteins*
-
N-Methyl-3,4-methylenedioxyamphetamine / pharmacology*
-
Nerve Tissue Proteins*
-
Paroxetine / pharmacology
-
Radioligand Assay
-
Rats
-
Rats, Sprague-Dawley
-
Serotonin / metabolism*
-
Serotonin Agents / pharmacology*
-
Serotonin Antagonists / pharmacology
-
Serotonin Plasma Membrane Transport Proteins
Substances
-
Carrier Proteins
-
Membrane Glycoproteins
-
Membrane Transport Proteins
-
Nerve Tissue Proteins
-
Serotonin Agents
-
Serotonin Antagonists
-
Serotonin Plasma Membrane Transport Proteins
-
Slc6a4 protein, rat
-
Serotonin
-
Paroxetine
-
Hydroxyindoleacetic Acid
-
N-Methyl-3,4-methylenedioxyamphetamine
-
Fenclonine